Literature DB >> 18949731

Endostatin, an antiangiogenic protein, is expressed in the unilateral ureteral obstruction mice model.

Thiago T Maciel1, Enia L Coutinho, Debora Soares, Edurardo Achar, Nestor Schor, Maria H Bellini.   

Abstract

BACKGROUND: Extracellular matrix accumulation, epithelial-to-mesenchymal transition, tubular atrophy and loss of peritubular capillary network are hallmarks of tubulointerstitial injury in progressive renal diseases. In this study, we analyzed endostatin expression in kidneys subjected to unilateral ureteral obstruction (UUO).
METHODS: Collagen XVIII mRNA expression was evaluated by real-time polymerase chain reaction (PCR). Endostatin and CD31 protein levels were analyzed by Western blot and immunohistochemistry. In vitro quantification of collagen XVIII and fibrosis-related genes in HK2 cells was performed by real-time PCR.
RESULTS: UUO significantly increased collagen XVIII mRNA expression and released a 30-kDa endostatin fragment. Immunohistochemistry revealed endostatin expression increased in injured tissue, mainly on tubular cells. Of interest, expression of CD31 was significantly reduced by UUO. Endostatin administration in vitro did not modify the expression of genes related to fibrosis development. However, in vitro TGF-beta1 administration induced expression of collagen XVIII/endostatin mRNA in human tubular cells.
CONCLUSION: Endostatin is expressed during the progression of renal fibrosis in vitro and in vivo, suggesting a role for endostatin in development of tubulointerstitial injury.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18949731

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  9 in total

Review 1.  Hypoxia and Dysregulated Angiogenesis in Kidney Disease.

Authors:  Shinji Tanaka; Tetsuhiro Tanaka; Masaomi Nangaku
Journal:  Kidney Dis (Basel)       Date:  2015-04-15

Review 2.  Endostatin in Renal and Cardiovascular Diseases.

Authors:  Mei Li; Zoran Popovic; Chang Chu; Bernhard K Krämer; Berthold Hocher
Journal:  Kidney Dis (Basel)       Date:  2021-09-09

3.  Differential expression of proteoglycans in tissue remodeling and lymphangiogenesis after experimental renal transplantation in rats.

Authors:  Heleen Rienstra; Kirankumar Katta; Johanna W A M Celie; Harry van Goor; Gerjan Navis; Jacob van den Born; Jan-Luuk Hillebrands
Journal:  PLoS One       Date:  2010-02-05       Impact factor: 3.240

Review 4.  Peritubular capillary rarefaction: a new therapeutic target in chronic kidney disease.

Authors:  Yujiro Kida; Bie Nga Tchao; Ikuyo Yamaguchi
Journal:  Pediatr Nephrol       Date:  2013-03-10       Impact factor: 3.714

Review 5.  Renal vascular structure and rarefaction.

Authors:  Alejandro R Chade
Journal:  Compr Physiol       Date:  2013-04       Impact factor: 9.090

6.  Validation of an enzyme-linked immunosorbent assay (ELISA) for quantification of endostatin levels in mice as a biomarker of developing glomerulonephritis.

Authors:  Jacqueline Wallwitz; Petra Aigner; Elisabeth Gadermaier; Eva Bauer; Emilio Casanova; Anton Bauer; Dagmar Stoiber
Journal:  PLoS One       Date:  2019-08-12       Impact factor: 3.240

7.  Quantitative proteomic profiling of extracellular matrix and site-specific collagen post-translational modifications in an in vitro model of lung fibrosis.

Authors:  Juliane Merl-Pham; Trayambak Basak; Larissa Knüppel; Deepak Ramanujam; Mark Athanason; Jürgen Behr; Stefan Engelhardt; Oliver Eickelberg; Stefanie M Hauck; Roberto Vanacore; Claudia A Staab-Weijnitz
Journal:  Matrix Biol Plus       Date:  2019-04-13

8.  Suppression of lung cancer in murine model: treated by combination of recombinant human endostsatin adenovirus with low-dose cisplatin.

Authors:  Rui Z Bai; Yang Wu; Quan Liu; Ke Xie; Yu Q Wei; Yong S Wang; Kang Liu; Yan Luo; Jing M Su; Bing Hu; Ji Y Liu; Qiu Li; Ting Niu; Zhi W Zhao; Li Yang
Journal:  J Exp Clin Cancer Res       Date:  2009-03-05

9.  Derivation and validation of plasma endostatin for predicting renal recovery from acute kidney injury: a prospective validation study.

Authors:  Hui-Miao Jia; Yue Zheng; Li-Feng Huang; Xin Xin; Wen-Liang Ma; Yi-Jia Jiang; Xi Zheng; Shu-Yan Guo; Wen-Xiong Li
Journal:  Crit Care       Date:  2018-11-16       Impact factor: 9.097

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.